Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 6/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.43 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6708577 | 0.92 | ALB (0.54) | ALBKMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL6709196 | 0.90 | THRB (0.46) | ALBKMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL6707643 | 0.89 | ALB (0.64) | ALBKMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL6711760 | 0.87 | ALB (0.53) | ALBKMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL6710075 | 0.85 | MAPT (0.42) | KMT2AMEN1ALDH1A1SMN1; SMN2POLB | |
| SCHEMBL6710227 | 0.81 | ROCK1 (0.43) | KMT2AMEN1LMNA | |
| SCHEMBL6711606 | 0.79 | GRIK1 (0.42) | KMT2AMEN1LMNASMN1; SMN2L3MBTL1 | |
| SCHEMBL6710300 | 0.79 | GRIK1 (0.38) | ALBKMT2AMEN1 | |
| SCHEMBL6709926 | 0.79 | ALB (0.55) | ALBKMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL6708518 | 0.79 | GRIK1 (0.39) | KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | ALB 1298/4885KMT2A 3181/4885MEN1 4100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.